Myriad Genetics | MYGN - Eps Gewinn Pro Aktie

Aktienkurs
4.35
Täglich Wechseln
-0.09 -2.03%
Monatlich
-14.03%
Jährlich
-45.63%
Q2 Prognose
4.61

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2025Q1 Mar/2026 -0.07 -0.03 Apr/30




Eps Veränderung Datum
Agilent USD 1.32 0.35 2025-12
Becton, Dickinson and Co. USD 2.91 1.05 2025-12
Bio-Rad Laboratories USD 2.51 0.25 2025-12
Bruker USD 0.59 0.14 2025-12
Danaher USD 2.23 0.34 2025-12
Hologic USD 1.04 0.09 2025-12
Illumina USD 1.35 0.01 2025-12
J&J USD 2.46 0.34 2025-12
Mettler Toledo International USD 13.36 2.21 2025-12
Myriad Genetics USD 0.04 0.33 2025-12
OraSure Technologies USD -0.18 0 2025-12
Pacific Biosciences Of California USD -0.17 0.12 2025-12
Quest Diagnostics USD 2.42 0.18 2025-12
Quidel USD 0.46 0.34 2025-12
Repligen USD 0.49 0.03 2025-12
Revvity USD 1.7 0.52 2025-12
Standard Biotools USD 0.04 0.13 2025-12
Thermo Fisher Scientific USD 6.57 0.78 2025-12
Veracyte USD 0.53 0.02 2025-12
Waters USD 4.53 1.13 2025-12